Maravai Lifesciences Holdings, Inc. (MRVI)
6.935
-0.26
(-3.55%)
USD |
NASDAQ |
Sep 09, 16:00
6.935
0.00 (0.00%)
After-Hours: 18:27
Maravai Lifesciences Holdings Enterprise Value : 1.328B for Sept. 8, 2026
Enterprise Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Enterprise Value Data
| Date | Value |
|---|---|
| September 08, 2026 | 1.328B |
| September 04, 2026 | 1.347B |
| September 03, 2026 | 1.354B |
| September 02, 2026 | 1.356B |
| September 01, 2026 | 1.344B |
| August 31, 2026 | 1.395B |
| August 28, 2026 | 1.401B |
| August 27, 2026 | 1.503B |
| August 26, 2026 | 1.582B |
| August 25, 2026 | 1.597B |
| August 24, 2026 | 1.512B |
| August 21, 2026 | 1.543B |
| August 20, 2026 | 1.491B |
| August 19, 2026 | 1.332B |
| August 18, 2026 | 1.112B |
| August 17, 2026 | 1.103B |
| August 14, 2026 | 1.106B |
| August 13, 2026 | 1.118B |
| August 12, 2026 | 1.118B |
| August 11, 2026 | 1.122B |
| August 10, 2026 | 1.161B |
| August 07, 2026 | 1.185B |
| August 06, 2026 | 1.188B |
| August 05, 2026 | 1.211B |
| August 04, 2026 | 1.214B |
| Date | Value |
|---|---|
| August 03, 2026 | 1.213B |
| July 31, 2026 | 1.235B |
| July 30, 2026 | 1.262B |
| July 29, 2026 | 1.238B |
| July 28, 2026 | 1.278B |
| July 27, 2026 | 1.253B |
| July 24, 2026 | 1.264B |
| July 23, 2026 | 1.307B |
| July 22, 2026 | 1.314B |
| July 21, 2026 | 1.314B |
| July 20, 2026 | 1.298B |
| July 17, 2026 | 1.335B |
| July 16, 2026 | 1.313B |
| July 15, 2026 | 1.305B |
| July 14, 2026 | 1.226B |
| July 13, 2026 | 1.204B |
| July 10, 2026 | 1.164B |
| July 09, 2026 | 1.146B |
| July 08, 2026 | 1.115B |
| July 07, 2026 | 1.138B |
| July 06, 2026 | 1.136B |
| July 02, 2026 | 1.156B |
| July 01, 2026 | 1.173B |
| June 30, 2026 | 1.186B |
| June 29, 2026 | 1.205B |
Enterprise Value Definition
EV is considered the theoretical purchase ("takeover") price of a business because a purchaser would take on the company's debt, while pocketing the company's cash and gaining a right to all of the company's future earnings.
Enterprise Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Enterprise Value Benchmarks
| Danaher Corp. | 167.78B |
| Illumina, Inc. | 33.23B |
| Bio-Techne Corp. | 11.31B |
| Waters Corp. | 44.49B |
| West Pharmaceutical Services, Inc. | 23.66B |
Enterprise Value Related Metrics
| Net Income (Quarterly) | -21.63M |
| Revenue (Quarterly) | 51.44M |
| Total Expenses (Quarterly) | 63.86M |
| EPS Diluted (Quarterly) | -0.0839 |
| Gross Profit Margin (Quarterly) | 40.14% |
| Profit Margin (Quarterly) | -42.05% |
| Earnings Yield | -7.67% |
| Normalized Earnings Yield | -1.252 |